Table 3. Cell viability of SH-SY5Y and HEK293 cells treated with the compounds for 24 h. Data are mean ± SD (n = 3).

Compounds	IC50 (μM)
	SH-SY5Y	HEK-293	Selectivity
10a	8.22 ± 0.12	78.21 ± 0.42	9.5
10b	15.82 ± 0.20	43.42 ± 0.36	2.7
10c	11.93 ± 0.20	46.91 ± 0.32	3.9
10d	16.37 ± 0.21	75.22 ± 0.35	4.6
10e	33.19 ± 0.25	68.95 ± 0.41	2.1
10f	7.33 ± 0.11	33.18 ± 0.55	4.5
10g	12.94 ± 0.13	86.45 ± 0.52	6.7
10h	7.42 ± 0.07	78.38 ± 0.57	10.6
10i	4.26 ± 0.08	37.39 ± 0.55	8.8
10j	6.75 ± 0.18	67.43 ± 0.47	10.0
10k	8.11 ± 0.07	81.71 ± 0.56	10.1
10l	42.15 ± 0.37	92.86 ± 0.71	2.2
10m	28.33 ± 0.26	46.45 ± 0.45	1.6
10n	5.22 ± 0.12	38.42 ± 0.19	7.4
Sorafenib	3.88 ± 0.12	16.22 ± 0.14	4.2